C57BL/6NTac-Bap1tm1a(EUCOMM)Hmgu/WtsiIeg
Status | Available to order |
EMMA ID | EM:08891 |
Citation information | RRID:IMSR_EM:08891 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Bap1tm1a(EUCOMM)Hmgu/WtsiIeg |
Alternative name | HEPD0526_2_G01 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Bap1tm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Bap1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0526_2_G01. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Uveal melanoma / Orphanet_39044
- BAP1-related tumor predisposition syndrome / Orphanet_289539
- Meningioma / Orphanet_2495
- Pleural mesothelioma / Orphanet_50251
- Non-specific syndromic intellectual disability / Orphanet_528084
IMPC phenotypes (allele matching)
MGI phenotypes (gene matching)
- increased mammary adenocarcinoma incidence / MGI
- no phenotypic analysis / MGI
- embryonic growth retardation / MGI
- increased squamous cell carcinoma incidence / MGI
- increased incidence of tumors by chemical induction / MGI
- hematopoietic system phenotype / MGI
- increased ovary tumor incidence / MGI
- increased lung carcinoma incidence / MGI
- abnormal DNA methylation / MGI
- increased skin tumor incidence / MGI
- increased mesothelioma incidence / MGI
- increased pancreatic islet cell carcinoma incidence / MGI
- embryonic lethality between implantation and placentation, complete penetrance / MGI
- embryonic lethality during organogenesis, complete penetrance / MGI
- abnormal epigenetic regulation of gene expression / MGI
- increased granulosa cell tumor incidence / MGI
- increased lymphoma incidence / MGI
- increased colon tumor incidence / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).